Furthermore, stratified analysis results showed that our model performed well in predicting the outcome of some HCC subgroups (mainly including male patients, patients aged ≤ 60 years, AJCC stage I patients, patients without vascular invasion and patients with low AFP levels). This evidence concerns the gene AFP and hepatocellular carcinoma.